nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.504	1	CpDpCtD
Diflunisal—ALB—chronic obstructive pulmonary disease	0.269	1	CbGaD
Diflunisal—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.067	0.707	CbGbCtD
Diflunisal—ALB—Prednisone—chronic obstructive pulmonary disease	0.0277	0.293	CbGbCtD
Diflunisal—Aminosalicylic Acid—MPO—chronic obstructive pulmonary disease	0.00116	0.333	CrCbGaD
Diflunisal—Niclosamide—CYP1A2—chronic obstructive pulmonary disease	0.00101	0.29	CrCbGaD
Diflunisal—Mesalazine—MPO—chronic obstructive pulmonary disease	0.000908	0.261	CrCbGaD
Diflunisal—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.000542	0.00591	CcSEcCtD
Diflunisal—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.000538	0.00586	CcSEcCtD
Diflunisal—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.000536	0.00585	CcSEcCtD
Diflunisal—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.000532	0.0058	CcSEcCtD
Diflunisal—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.000528	0.00576	CcSEcCtD
Diflunisal—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.000526	0.00574	CcSEcCtD
Diflunisal—Peptic ulcer—Prednisone—chronic obstructive pulmonary disease	0.000517	0.00564	CcSEcCtD
Diflunisal—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.000512	0.00558	CcSEcCtD
Diflunisal—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.000509	0.00555	CcSEcCtD
Diflunisal—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.000505	0.0055	CcSEcCtD
Diflunisal—Tension—Aminophylline—chronic obstructive pulmonary disease	0.000495	0.0054	CcSEcCtD
Diflunisal—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00049	0.00535	CcSEcCtD
Diflunisal—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00049	0.00534	CcSEcCtD
Diflunisal—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.000486	0.00531	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.000477	0.0052	CcSEcCtD
Diflunisal—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.000469	0.00511	CcSEcCtD
Diflunisal—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.000468	0.00511	CcSEcCtD
Diflunisal—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.000468	0.00511	CcSEcCtD
Diflunisal—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000455	0.00496	CcSEcCtD
Diflunisal—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00493	CcSEcCtD
Diflunisal—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00493	CcSEcCtD
Diflunisal—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.000448	0.00489	CcSEcCtD
Diflunisal—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.000446	0.00486	CcSEcCtD
Diflunisal—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.000445	0.00485	CcSEcCtD
Diflunisal—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000443	0.00483	CcSEcCtD
Diflunisal—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000442	0.00482	CcSEcCtD
Diflunisal—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000435	0.00474	CcSEcCtD
Diflunisal—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000432	0.00471	CcSEcCtD
Diflunisal—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00043	0.00469	CcSEcCtD
Diflunisal—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00465	CcSEcCtD
Diflunisal—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.000425	0.00463	CcSEcCtD
Diflunisal—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.000425	0.00463	CcSEcCtD
Diflunisal—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000422	0.00461	CcSEcCtD
Diflunisal—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.00458	CcSEcCtD
Diflunisal—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.000418	0.00456	CcSEcCtD
Diflunisal—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000412	0.00449	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—HMOX1—chronic obstructive pulmonary disease	0.000409	0.0118	CbGpPWpGaD
Diflunisal—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000408	0.00445	CcSEcCtD
Diflunisal—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000408	0.00445	CcSEcCtD
Diflunisal—PTGS2—leg—chronic obstructive pulmonary disease	0.000408	0.203	CbGeAlD
Diflunisal—UGT1A8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000407	0.0118	CbGpPWpGaD
Diflunisal—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000405	0.00442	CcSEcCtD
Diflunisal—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000405	0.00442	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.000403	0.0116	CbGpPWpGaD
Diflunisal—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000392	0.00428	CcSEcCtD
Diflunisal—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000392	0.00428	CcSEcCtD
Diflunisal—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000389	0.00424	CcSEcCtD
Diflunisal—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000389	0.00424	CcSEcCtD
Diflunisal—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.00423	CcSEcCtD
Diflunisal—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000388	0.00423	CcSEcCtD
Diflunisal—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000387	0.00422	CcSEcCtD
Diflunisal—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000386	0.00421	CcSEcCtD
Diflunisal—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000382	0.00417	CcSEcCtD
Diflunisal—Tension—Arformoterol—chronic obstructive pulmonary disease	0.000377	0.00411	CcSEcCtD
Diflunisal—Tension—Formoterol—chronic obstructive pulmonary disease	0.000377	0.00411	CcSEcCtD
Diflunisal—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.000373	0.00407	CcSEcCtD
Diflunisal—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.000373	0.00407	CcSEcCtD
Diflunisal—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000372	0.00406	CcSEcCtD
Diflunisal—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—MMP1—chronic obstructive pulmonary disease	0.000372	0.0107	CbGpPWpGaD
Diflunisal—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000369	0.00402	CcSEcCtD
Diflunisal—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.00402	CcSEcCtD
Diflunisal—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000367	0.004	CcSEcCtD
Diflunisal—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.000364	0.00397	CcSEcCtD
Diflunisal—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000362	0.00395	CcSEcCtD
Diflunisal—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000361	0.00394	CcSEcCtD
Diflunisal—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000358	0.0039	CcSEcCtD
Diflunisal—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.0039	CcSEcCtD
Diflunisal—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000356	0.00388	CcSEcCtD
Diflunisal—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000352	0.00384	CcSEcCtD
Diflunisal—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000351	0.00383	CcSEcCtD
Diflunisal—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.00383	CcSEcCtD
Diflunisal—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000351	0.00383	CcSEcCtD
Diflunisal—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000348	0.0038	CcSEcCtD
Diflunisal—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000348	0.0038	CcSEcCtD
Diflunisal—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000343	0.00375	CcSEcCtD
Diflunisal—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000342	0.00373	CcSEcCtD
Diflunisal—UGT1A8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00034	0.0098	CbGpPWpGaD
Diflunisal—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000339	0.0037	CcSEcCtD
Diflunisal—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.0037	CcSEcCtD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000337	0.00972	CbGpPWpGaD
Diflunisal—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000337	0.00367	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000335	0.00967	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—SOD3—chronic obstructive pulmonary disease	0.000333	0.00961	CbGpPWpGaD
Diflunisal—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000332	0.00362	CcSEcCtD
Diflunisal—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000332	0.00362	CcSEcCtD
Diflunisal—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.00361	CcSEcCtD
Diflunisal—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000327	0.00357	CcSEcCtD
Diflunisal—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000327	0.00356	CcSEcCtD
Diflunisal—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000327	0.00356	CcSEcCtD
Diflunisal—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000326	0.00355	CcSEcCtD
Diflunisal—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000325	0.00355	CcSEcCtD
Diflunisal—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00354	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—CRP—chronic obstructive pulmonary disease	0.00032	0.00924	CbGpPWpGaD
Diflunisal—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.00349	CcSEcCtD
Diflunisal—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000318	0.00347	CcSEcCtD
Diflunisal—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000317	0.00346	CcSEcCtD
Diflunisal—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00342	CcSEcCtD
Diflunisal—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000313	0.00342	CcSEcCtD
Diflunisal—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00342	CcSEcCtD
Diflunisal—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000313	0.00342	CcSEcCtD
Diflunisal—UGT1A8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000312	0.00901	CbGpPWpGaD
Diflunisal—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000309	0.00337	CcSEcCtD
Diflunisal—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000308	0.00336	CcSEcCtD
Diflunisal—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00335	CcSEcCtD
Diflunisal—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000307	0.00335	CcSEcCtD
Diflunisal—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000303	0.00331	CcSEcCtD
Diflunisal—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00328	CcSEcCtD
Diflunisal—UGT1A8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000296	0.00854	CbGpPWpGaD
Diflunisal—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00323	CcSEcCtD
Diflunisal—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000296	0.00323	CcSEcCtD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000291	0.00841	CbGpPWpGaD
Diflunisal—TTR—respiratory system—chronic obstructive pulmonary disease	0.000291	0.145	CbGeAlD
Diflunisal—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000291	0.00318	CcSEcCtD
Diflunisal—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000291	0.00317	CcSEcCtD
Diflunisal—PTGS1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000289	0.00833	CbGpPWpGaD
Diflunisal—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000286	0.00312	CcSEcCtD
Diflunisal—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00312	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.000285	0.00822	CbGpPWpGaD
Diflunisal—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000283	0.00309	CcSEcCtD
Diflunisal—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.00309	CcSEcCtD
Diflunisal—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.00308	CcSEcCtD
Diflunisal—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000282	0.00307	CcSEcCtD
Diflunisal—TTR—Non-integrin membrane-ECM interactions—TGFB1—chronic obstructive pulmonary disease	0.00028	0.00808	CbGpPWpGaD
Diflunisal—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000279	0.00305	CcSEcCtD
Diflunisal—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000279	0.00305	CcSEcCtD
Diflunisal—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000278	0.00304	CcSEcCtD
Diflunisal—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000278	0.00304	CcSEcCtD
Diflunisal—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000277	0.00303	CcSEcCtD
Diflunisal—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00301	CcSEcCtD
Diflunisal—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00301	CcSEcCtD
Diflunisal—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000275	0.00301	CcSEcCtD
Diflunisal—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000275	0.003	CcSEcCtD
Diflunisal—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000273	0.00298	CcSEcCtD
Diflunisal—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000272	0.00297	CcSEcCtD
Diflunisal—ALB—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.000271	0.00782	CbGpPWpGaD
Diflunisal—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00295	CcSEcCtD
Diflunisal—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00027	0.00295	CcSEcCtD
Diflunisal—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00027	0.00295	CcSEcCtD
Diflunisal—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000268	0.00292	CcSEcCtD
Diflunisal—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.00292	CcSEcCtD
Diflunisal—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.00292	CcSEcCtD
Diflunisal—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.000267	0.00771	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000266	0.00768	CbGpPWpGaD
Diflunisal—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.0029	CcSEcCtD
Diflunisal—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000264	0.00289	CcSEcCtD
Diflunisal—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00288	CcSEcCtD
Diflunisal—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000263	0.00287	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000262	0.00757	CbGpPWpGaD
Diflunisal—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000262	0.00285	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—MMP12—chronic obstructive pulmonary disease	0.000261	0.00753	CbGpPWpGaD
Diflunisal—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.00284	CcSEcCtD
Diflunisal—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00283	CcSEcCtD
Diflunisal—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000259	0.00283	CcSEcCtD
Diflunisal—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000258	0.00282	CcSEcCtD
Diflunisal—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000258	0.00282	CcSEcCtD
Diflunisal—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000258	0.00281	CcSEcCtD
Diflunisal—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.0028	CcSEcCtD
Diflunisal—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000257	0.0028	CcSEcCtD
Diflunisal—TTR—connective tissue—chronic obstructive pulmonary disease	0.000256	0.127	CbGeAlD
Diflunisal—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000256	0.00279	CcSEcCtD
Diflunisal—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000256	0.00279	CcSEcCtD
Diflunisal—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000255	0.00278	CcSEcCtD
Diflunisal—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.00276	CcSEcCtD
Diflunisal—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000251	0.00274	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000251	0.00274	CcSEcCtD
Diflunisal—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000249	0.00271	CcSEcCtD
Diflunisal—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000249	0.00271	CcSEcCtD
Diflunisal—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000248	0.0027	CcSEcCtD
Diflunisal—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.0027	CcSEcCtD
Diflunisal—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000247	0.00269	CcSEcCtD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000245	0.00707	CbGpPWpGaD
Diflunisal—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000245	0.00267	CcSEcCtD
Diflunisal—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000244	0.00267	CcSEcCtD
Diflunisal—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000244	0.00267	CcSEcCtD
Diflunisal—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00266	CcSEcCtD
Diflunisal—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000244	0.00266	CcSEcCtD
Diflunisal—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000243	0.00265	CcSEcCtD
Diflunisal—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000243	0.00265	CcSEcCtD
Diflunisal—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000242	0.00264	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000238	0.00687	CbGpPWpGaD
Diflunisal—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00256	CcSEcCtD
Diflunisal—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000234	0.00255	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.000232	0.0067	CbGpPWpGaD
Diflunisal—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00252	CcSEcCtD
Diflunisal—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00252	CcSEcCtD
Diflunisal—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000231	0.00251	CcSEcCtD
Diflunisal—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.00251	CcSEcCtD
Diflunisal—PTGS2—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000229	0.00661	CbGpPWpGaD
Diflunisal—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000226	0.00247	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000225	0.00649	CbGpPWpGaD
Diflunisal—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000225	0.00245	CcSEcCtD
Diflunisal—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000225	0.00245	CcSEcCtD
Diflunisal—ALB—Vitamin B12 Metabolism—MPO—chronic obstructive pulmonary disease	0.000224	0.00645	CbGpPWpGaD
Diflunisal—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000222	0.00242	CcSEcCtD
Diflunisal—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000222	0.00242	CcSEcCtD
Diflunisal—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00022	0.0024	CcSEcCtD
Diflunisal—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00238	CcSEcCtD
Diflunisal—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000217	0.00237	CcSEcCtD
Diflunisal—ALB—Selenium Micronutrient Network—SOD3—chronic obstructive pulmonary disease	0.000215	0.00621	CbGpPWpGaD
Diflunisal—Salicylic acid—ALB—chronic obstructive pulmonary disease	0.000215	0.0618	CrCbGaD
Diflunisal—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000214	0.00234	CcSEcCtD
Diflunisal—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000214	0.00234	CcSEcCtD
Diflunisal—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00231	CcSEcCtD
Diflunisal—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00021	0.00229	CcSEcCtD
Diflunisal—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00021	0.00605	CbGpPWpGaD
Diflunisal—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000209	0.00228	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—CXCL8—chronic obstructive pulmonary disease	0.000208	0.00601	CbGpPWpGaD
Diflunisal—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000207	0.00226	CcSEcCtD
Diflunisal—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000207	0.00226	CcSEcCtD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000203	0.00586	CbGpPWpGaD
Diflunisal—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000203	0.00221	CcSEcCtD
Diflunisal—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000202	0.00221	CcSEcCtD
Diflunisal—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000202	0.00583	CbGpPWpGaD
Diflunisal—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000199	0.00217	CcSEcCtD
Diflunisal—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000199	0.00217	CcSEcCtD
Diflunisal—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00215	CcSEcCtD
Diflunisal—Rash—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00215	CcSEcCtD
Diflunisal—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000197	0.00215	CcSEcCtD
Diflunisal—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000197	0.00215	CcSEcCtD
Diflunisal—Headache—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00214	CcSEcCtD
Diflunisal—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00214	CcSEcCtD
Diflunisal—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000196	0.00214	CcSEcCtD
Diflunisal—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00213	CcSEcCtD
Diflunisal—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000195	0.00213	CcSEcCtD
Diflunisal—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic obstructive pulmonary disease	0.000194	0.0056	CbGpPWpGaD
Diflunisal—Rash—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00211	CcSEcCtD
Diflunisal—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000193	0.00211	CcSEcCtD
Diflunisal—Headache—Montelukast—chronic obstructive pulmonary disease	0.000192	0.0021	CcSEcCtD
Diflunisal—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00019	0.00207	CcSEcCtD
Diflunisal—Flurbiprofen—ALB—chronic obstructive pulmonary disease	0.000188	0.0542	CrCbGaD
Diflunisal—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000188	0.00205	CcSEcCtD
Diflunisal—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000187	0.00204	CcSEcCtD
Diflunisal—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00203	CcSEcCtD
Diflunisal—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000186	0.00203	CcSEcCtD
Diflunisal—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000186	0.00203	CcSEcCtD
Diflunisal—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000186	0.00203	CcSEcCtD
Diflunisal—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000186	0.00203	CcSEcCtD
Diflunisal—PTGS2—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000185	0.00535	CbGpPWpGaD
Diflunisal—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.00202	CcSEcCtD
Diflunisal—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.00199	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000183	0.00527	CbGpPWpGaD
Diflunisal—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000182	0.00199	CcSEcCtD
Diflunisal—ALB—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.000182	0.00525	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000181	0.00523	CbGpPWpGaD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000179	0.00517	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000179	0.00515	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000178	0.00513	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000178	0.00512	CbGpPWpGaD
Diflunisal—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000176	0.00192	CcSEcCtD
Diflunisal—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00188	CcSEcCtD
Diflunisal—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00185	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00017	0.00185	CcSEcCtD
Diflunisal—PTGS2—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.000169	0.00488	CbGpPWpGaD
Diflunisal—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000167	0.00182	CcSEcCtD
Diflunisal—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.0048	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.000166	0.00478	CbGpPWpGaD
Diflunisal—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000164	0.00179	CcSEcCtD
Diflunisal—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000161	0.00176	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000158	0.00455	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000158	0.00455	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000155	0.00448	CbGpPWpGaD
Diflunisal—TTR—lung—chronic obstructive pulmonary disease	0.000155	0.0768	CbGeAlD
Diflunisal—UGT1A8—Metabolism—GC—chronic obstructive pulmonary disease	0.000153	0.00443	CbGpPWpGaD
Diflunisal—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.00167	CcSEcCtD
Diflunisal—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00166	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000147	0.00425	CbGpPWpGaD
Diflunisal—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000147	0.00424	CbGpPWpGaD
Diflunisal—PTGS2—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000145	0.00418	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000145	0.00417	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000144	0.00414	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000143	0.00412	CbGpPWpGaD
Diflunisal—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000142	0.00155	CcSEcCtD
Diflunisal—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00014	0.00152	CcSEcCtD
Diflunisal—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000138	0.00151	CcSEcCtD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000137	0.00394	CbGpPWpGaD
Diflunisal—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000136	0.00148	CcSEcCtD
Diflunisal—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000135	0.00148	CcSEcCtD
Diflunisal—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00147	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.000134	0.00387	CbGpPWpGaD
Diflunisal—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000133	0.00145	CcSEcCtD
Diflunisal—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000129	0.00373	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000128	0.00369	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000128	0.00369	CbGpPWpGaD
Diflunisal—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00136	CcSEcCtD
Diflunisal—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00134	CcSEcCtD
Diflunisal—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000123	0.00134	CcSEcCtD
Diflunisal—Shock—Prednisone—chronic obstructive pulmonary disease	0.000121	0.00132	CcSEcCtD
Diflunisal—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000119	0.0013	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000118	0.00341	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	0.000118	0.00339	CbGpPWpGaD
Diflunisal—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000117	0.00128	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000117	0.00337	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000116	0.00335	CbGpPWpGaD
Diflunisal—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000112	0.00122	CcSEcCtD
Diflunisal—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00122	CcSEcCtD
Diflunisal—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000111	0.00121	CcSEcCtD
Diflunisal—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000109	0.00118	CcSEcCtD
Diflunisal—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000107	0.0031	CbGpPWpGaD
Diflunisal—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000107	0.00117	CcSEcCtD
Diflunisal—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00117	CcSEcCtD
Diflunisal—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00117	CcSEcCtD
Diflunisal—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00116	CcSEcCtD
Diflunisal—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000106	0.00116	CcSEcCtD
Diflunisal—PTGS1—respiratory system—chronic obstructive pulmonary disease	0.000106	0.0526	CbGeAlD
Diflunisal—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000106	0.00305	CbGpPWpGaD
Diflunisal—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000105	0.00115	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000102	0.00294	CbGpPWpGaD
Diflunisal—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000102	0.00111	CcSEcCtD
Diflunisal—PTGS2—respiratory system—chronic obstructive pulmonary disease	0.000101	0.0503	CbGeAlD
Diflunisal—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000101	0.0011	CcSEcCtD
Diflunisal—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.0011	CcSEcCtD
Diflunisal—Urticaria—Prednisone—chronic obstructive pulmonary disease	9.79e-05	0.00107	CcSEcCtD
Diflunisal—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	9.74e-05	0.00106	CcSEcCtD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	9.6e-05	0.00277	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	9.57e-05	0.00276	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	9.42e-05	0.00272	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	9.4e-05	0.00271	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	9.4e-05	0.00271	CbGpPWpGaD
Diflunisal—PTGS1—connective tissue—chronic obstructive pulmonary disease	9.33e-05	0.0463	CbGeAlD
Diflunisal—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	9.09e-05	0.00262	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	9.09e-05	0.00262	CbGpPWpGaD
Diflunisal—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	9.08e-05	0.000991	CcSEcCtD
Diflunisal—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	9.07e-05	0.00262	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	9.03e-05	0.00261	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	8.96e-05	0.00259	CbGpPWpGaD
Diflunisal—PTGS2—connective tissue—chronic obstructive pulmonary disease	8.92e-05	0.0443	CbGeAlD
Diflunisal—Asthenia—Prednisone—chronic obstructive pulmonary disease	8.84e-05	0.000965	CcSEcCtD
Diflunisal—Pruritus—Prednisone—chronic obstructive pulmonary disease	8.72e-05	0.000951	CcSEcCtD
Diflunisal—PTGS1—smooth muscle tissue—chronic obstructive pulmonary disease	8.53e-05	0.0424	CbGeAlD
Diflunisal—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	8.43e-05	0.00092	CcSEcCtD
Diflunisal—UGT1A8—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.38e-05	0.00242	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	8.34e-05	0.00241	CbGpPWpGaD
Diflunisal—PTGS2—bronchus—chronic obstructive pulmonary disease	8.34e-05	0.0414	CbGeAlD
Diflunisal—UGT1A8—Metabolism—GCLC—chronic obstructive pulmonary disease	8.29e-05	0.00239	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	8.23e-05	0.00238	CbGpPWpGaD
Diflunisal—PTGS2—smooth muscle tissue—chronic obstructive pulmonary disease	8.16e-05	0.0405	CbGeAlD
Diflunisal—Dizziness—Prednisone—chronic obstructive pulmonary disease	8.15e-05	0.000889	CcSEcCtD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	7.84e-05	0.00226	CbGpPWpGaD
Diflunisal—Vomiting—Prednisone—chronic obstructive pulmonary disease	7.84e-05	0.000855	CcSEcCtD
Diflunisal—PTGS1—trachea—chronic obstructive pulmonary disease	7.83e-05	0.0389	CbGeAlD
Diflunisal—TTR—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	7.81e-05	0.00225	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	7.81e-05	0.00225	CbGpPWpGaD
Diflunisal—Rash—Prednisone—chronic obstructive pulmonary disease	7.77e-05	0.000848	CcSEcCtD
Diflunisal—Dermatitis—Prednisone—chronic obstructive pulmonary disease	7.76e-05	0.000847	CcSEcCtD
Diflunisal—Headache—Prednisone—chronic obstructive pulmonary disease	7.72e-05	0.000842	CcSEcCtD
Diflunisal—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	7.6e-05	0.00219	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CTGF—chronic obstructive pulmonary disease	7.56e-05	0.00218	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	7.54e-05	0.00218	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.5e-05	0.00216	CbGpPWpGaD
Diflunisal—PTGS2—trachea—chronic obstructive pulmonary disease	7.48e-05	0.0372	CbGeAlD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	7.38e-05	0.00213	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	7.35e-05	0.00212	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	7.34e-05	0.00212	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	7.34e-05	0.00212	CbGpPWpGaD
Diflunisal—Nausea—Prednisone—chronic obstructive pulmonary disease	7.32e-05	0.000799	CcSEcCtD
Diflunisal—PTGS2—Spinal Cord Injury—LEP—chronic obstructive pulmonary disease	7.27e-05	0.0021	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	7.21e-05	0.00208	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	7.21e-05	0.00208	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	7.2e-05	0.00208	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	7.15e-05	0.00206	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	7.12e-05	0.00205	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TLR4—chronic obstructive pulmonary disease	7.12e-05	0.00205	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.97e-05	0.00201	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—NOS2—chronic obstructive pulmonary disease	6.78e-05	0.00195	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	6.68e-05	0.00193	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	6.59e-05	0.0019	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	6.44e-05	0.00186	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	6.37e-05	0.00184	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	6.3e-05	0.00182	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	6.28e-05	0.00181	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	6e-05	0.00173	CbGpPWpGaD
Diflunisal—TTR—Disease—HDAC2—chronic obstructive pulmonary disease	6e-05	0.00173	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	5.97e-05	0.00172	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	5.86e-05	0.00169	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	5.84e-05	0.00168	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	5.84e-05	0.00168	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.81e-05	0.00168	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.74e-05	0.00166	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.73e-05	0.00165	CbGpPWpGaD
Diflunisal—PTGS1—lung—chronic obstructive pulmonary disease	5.63e-05	0.0279	CbGeAlD
Diflunisal—TTR—Disease—KL—chronic obstructive pulmonary disease	5.57e-05	0.00161	CbGpPWpGaD
Diflunisal—PTGS2—lung—chronic obstructive pulmonary disease	5.38e-05	0.0267	CbGeAlD
Diflunisal—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	5.36e-05	0.00155	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.34e-05	0.00154	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	5.32e-05	0.00154	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.06e-05	0.00146	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APIP—chronic obstructive pulmonary disease	4.99e-05	0.00144	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CXCL8—chronic obstructive pulmonary disease	4.83e-05	0.00139	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	4.74e-05	0.00137	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.71e-05	0.00136	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL1B—chronic obstructive pulmonary disease	4.64e-05	0.00134	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.48e-05	0.00129	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	4.37e-05	0.00126	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	4.33e-05	0.00125	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	4.33e-05	0.00125	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.32e-05	0.00125	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	4.3e-05	0.00124	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	4.25e-05	0.00123	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	4.2e-05	0.00121	CbGpPWpGaD
Diflunisal—TTR—Disease—ERBB3—chronic obstructive pulmonary disease	4.18e-05	0.00121	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.16e-05	0.0012	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	4.13e-05	0.00119	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.13e-05	0.00119	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	4.05e-05	0.00117	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	4.03e-05	0.00116	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.99e-05	0.00115	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.98e-05	0.00115	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.9e-05	0.00113	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.82e-05	0.0011	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.79e-05	0.00109	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.79e-05	0.00109	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.76e-05	0.00109	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.6e-05	0.00104	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	3.6e-05	0.00104	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.55e-05	0.00103	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	3.53e-05	0.00102	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	3.5e-05	0.00101	CbGpPWpGaD
Diflunisal—TTR—Disease—NOS2—chronic obstructive pulmonary disease	3.48e-05	0.001	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ALB—chronic obstructive pulmonary disease	3.44e-05	0.000993	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	3.44e-05	0.000993	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.43e-05	0.00099	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TNF—chronic obstructive pulmonary disease	3.36e-05	0.00097	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.3e-05	0.000953	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—NOS3—chronic obstructive pulmonary disease	3.29e-05	0.00095	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	3.28e-05	0.000947	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.28e-05	0.000945	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.22e-05	0.000929	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GC—chronic obstructive pulmonary disease	3.21e-05	0.000927	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.000865	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.99e-05	0.000862	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.97e-05	0.000855	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.94e-05	0.000849	CbGpPWpGaD
Diflunisal—TTR—Disease—SERPINE1—chronic obstructive pulmonary disease	2.93e-05	0.000846	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.93e-05	0.000844	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.88e-05	0.00083	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.82e-05	0.000812	CbGpPWpGaD
Diflunisal—TTR—Disease—NOS3—chronic obstructive pulmonary disease	2.8e-05	0.000808	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.79e-05	0.000806	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.78e-05	0.000801	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.71e-05	0.000783	CbGpPWpGaD
Diflunisal—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.67e-05	0.000771	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.67e-05	0.00077	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.65e-05	0.000766	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.65e-05	0.000764	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.62e-05	0.000755	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.6e-05	0.00075	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.45e-05	0.000707	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.42e-05	0.000697	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.4e-05	0.000693	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.39e-05	0.000691	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.38e-05	0.000686	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.29e-05	0.00066	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.21e-05	0.000638	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	2.19e-05	0.00063	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.07e-05	0.000598	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.05e-05	0.000593	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.04e-05	0.000588	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.02e-05	0.000582	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.99e-05	0.000575	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.96e-05	0.000566	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.93e-05	0.000555	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.92e-05	0.000554	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.9e-05	0.000547	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.86e-05	0.000537	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—chronic obstructive pulmonary disease	1.85e-05	0.000534	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.84e-05	0.00053	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—chronic obstructive pulmonary disease	1.82e-05	0.000524	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.76e-05	0.000509	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HDAC2—chronic obstructive pulmonary disease	1.76e-05	0.000508	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.76e-05	0.000506	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.74e-05	0.000502	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.73e-05	0.0005	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.71e-05	0.000493	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KL—chronic obstructive pulmonary disease	1.64e-05	0.000472	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000467	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.58e-05	0.000457	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.57e-05	0.000454	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.53e-05	0.000442	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.51e-05	0.000436	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.46e-05	0.000421	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.44e-05	0.000415	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.42e-05	0.00041	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.41e-05	0.000408	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.41e-05	0.000406	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.4e-05	0.000405	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—chronic obstructive pulmonary disease	1.4e-05	0.000403	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.38e-05	0.000397	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.34e-05	0.000385	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.3e-05	0.000374	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.28e-05	0.000369	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.27e-05	0.000367	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB3—chronic obstructive pulmonary disease	1.23e-05	0.000354	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.22e-05	0.000351	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.2e-05	0.000346	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.18e-05	0.00034	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.12e-05	0.000323	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.07e-05	0.000308	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.06e-05	0.000306	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS2—chronic obstructive pulmonary disease	1.02e-05	0.000295	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	9.91e-06	0.000286	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.84e-06	0.000284	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.77e-06	0.000282	CbGpPWpGaD
Diflunisal—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.71e-06	0.00028	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	9.09e-06	0.000262	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	9.07e-06	0.000262	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.04e-06	0.000261	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	8.68e-06	0.00025	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SERPINE1—chronic obstructive pulmonary disease	8.62e-06	0.000249	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.57e-06	0.000247	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS3—chronic obstructive pulmonary disease	8.23e-06	0.000237	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	7.49e-06	0.000216	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—chronic obstructive pulmonary disease	7.2e-06	0.000208	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.89e-06	0.000199	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	5.58e-06	0.000161	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—chronic obstructive pulmonary disease	5.44e-06	0.000157	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—chronic obstructive pulmonary disease	5.33e-06	0.000154	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—chronic obstructive pulmonary disease	4.1e-06	0.000118	CbGpPWpGaD
